Exhibit and Poster Hall Hours
Monday, February 23 · 3:15 pm - 6:45 pm
Tuesday, February 24 · 10:15 am - 3:45 pm
Wednesday, February 25 · Closed

IBC主办之AsiaTIDES囊括从处方到药物投递法规之最新动向，是日本唯一与寡核酸(oligonucleotide)及胜肽(peptide)治疗战略相关之活动，会中将针对全球开发现状，进行广泛探讨。

日本的制药企业与学术机关之研究人员，对于这个极具未来潜力的寡核酸及胜肽治疗领域，特别是siRNA与mRNA适体(aptamer)及其相关分子等热门领域，抱持高度关注。本次活动将为日本关心此议题的各界人士，介绍全球开发的最新动态。注目焦点包括分析与生物分析技术、研究用RNA/DNA进行商品化时，合成及精制之规模放大，等主题讲座。

在主会议中，议题将涵盖此领域的药物投递与处方、包含最佳化与CMC开发前期临床试验与测试中化合物之全球相关案例学习、世界法规动向与市场环境、合作关系等。

Keynote Presentations
	Yoshikazu Nakamura, Ph.D. University of Tokyo; Ribomic Japan		Akira Yamada, Ph.D. Kurume University Research Center for Innovative Cancer Therapy Japan
	Junichi Yano, Ph.D. Nippon Shinyaku Co., Ltd. Japan		Takumi Kawabe, M.D., Ph.D. CanBas Japan
Featured Presentations
	Larry Gold, Ph.D. SomaLogic, Inc. USA		Rachel Meyers, Ph.D. Alnylam Pharmaceuticals USA

"AsiaTIDES: A first-of-its-kind meeting in Asia providing valuable insight into this niche area."
- Philip R. Oldfield, Ph.D., Scientific Director, Immunochemistry, Laboratory Sciences, Charles River Laboratories PCS-MTL, Canada

"The concentration of key industry players at TIDES is fantastic; the event is tremendously useful… Almost all the important decision-makers attended TIDES 2008."
- Simon May, Ph.D., Global Director, Business-to-Business Sales, Life Science Research, Thermo Fisher Scientific, United Kingdom

Attendees Praise the U.S. TIDES Conference

"The conference brought nearly all the experts in oligonucleotide therapeutics area under one roof, which made for an educational and entertaining meeting."
- Sumit Lutara, Senior Scientist, Pfizer, Inc, USA

"TIDES conferences in Europe and USA are always great places to learn about all the different aspects of oligonucleotide manufacturing, new diagnostic and therapeutic applications and ideal venues to network with colleagues and customers. I am excited that this great event now also starts in Asia."
- Peter Haima, Ph.D., Manager IVD Services, Eurogentec S.A., Belgium

"I have participated in TIDES since its inception and find it to be by far the most useful meeting in the field, for both the latest updates on drug development and regulatory issues, and also for networking with industry leaders."
- Michael S. Verlander, D. Phil., Executive Vice President, PolyPeptide Laboratories, Inc., USA and India

About the Organizers
This event is brought to you by the organizers of TIDES Peptide and Oligonucleotide® Technology and Product Development and EuroTIDES conferences, as well as Drug Discovery and Development of Innovative Therapeutics World Congress in Boston and Japan, IBC Life Sciences, an informa business. Other informa businesses include: Datamonitor, MedTRACK, SCRIP and Pharmaprojects. www.IBCLifeSciences.com and www.informa.com

Conference Language
The conference will be conducted in English without translation.